• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 PIK3CA 和 RAS 通路相关的综合征性血管畸形:临床和影像学评价。

Syndromic vascular malformations related to the PIK3CA and RAS pathways: A clinical and imaging review.

机构信息

Department of Radiology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan; Department of Radiology, Keio University School of Medicine, Tokyo, Japan.

Department of Radiology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan; Department of Radiology, Keio University School of Medicine, Tokyo, Japan; Department of Radiology, St. Luke's International Hospital, Tokyo, Japan.

出版信息

Clin Imaging. 2022 Sep;89:162-173. doi: 10.1016/j.clinimag.2022.06.017. Epub 2022 Jul 2.

DOI:10.1016/j.clinimag.2022.06.017
PMID:35849880
Abstract

Vascular malformations are a complex and diverse group of disorders. They may enlarge with time, impair quality of life, and even be fatal. While many are sporadic, others are part of inherited syndromes; several gene mutations responsible for vascular anomalies have been identified. The PI3K/AKT/mTOR and RAS/MEK/ERK cascades have been extensively studied, and new molecular agents targeting these cascades are being developed. Diagnostic imaging findings are increasingly used to guide genetic testing, and in some cases, pathognomonic imaging characteristics can lead to a specific diagnosis. We review each of the representative syndromes associated with PIK3CA and RAS cascades, with updates of the latest in clinical and imaging information.

摘要

血管畸形是一组复杂且多样的疾病。它们可能随时间而增大,降低生活质量,甚至危及生命。虽然许多是散发性的,但也有一些是遗传性综合征的一部分;已经确定了几种导致血管异常的基因突变。PI3K/AKT/mTOR 和 RAS/MEK/ERK 级联已被广泛研究,针对这些级联的新分子药物正在开发中。诊断成像发现越来越多地用于指导基因检测,在某些情况下,特征性成像特征可以导致特定的诊断。我们回顾了与 PIK3CA 和 RAS 级联相关的每个代表性综合征,并更新了最新的临床和影像学信息。

相似文献

1
Syndromic vascular malformations related to the PIK3CA and RAS pathways: A clinical and imaging review.与 PIK3CA 和 RAS 通路相关的综合征性血管畸形:临床和影像学评价。
Clin Imaging. 2022 Sep;89:162-173. doi: 10.1016/j.clinimag.2022.06.017. Epub 2022 Jul 2.
2
Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.Ran 是一种潜在的治疗靶点,适用于那些具有与 PI3K/Akt/mTORC1 和 Ras/MEK/ERK 通路激活相关的分子变化的癌细胞。
Clin Cancer Res. 2012 Jan 15;18(2):380-91. doi: 10.1158/1078-0432.CCR-11-2035. Epub 2011 Nov 16.
3
New and Emerging Targeted Therapies for Vascular Malformations.新型和新兴的血管畸形靶向治疗方法。
Am J Clin Dermatol. 2020 Oct;21(5):657-668. doi: 10.1007/s40257-020-00528-w.
4
Updates on Diagnosis and Treatment of PIK3CA-Related Overgrowth Spectrum.PIK3CA相关过度生长谱系疾病的诊断与治疗进展
Ann Plast Surg. 2023 May 1;90(5S Suppl 2):S209-S215. doi: 10.1097/SAP.0000000000003389. Epub 2022 Dec 21.
5
Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.PIK3CA 基因的体细胞框移突变通过触发 PI3K/AKT/mTOR 通路引起 CLOVES 综合征。
Hereditas. 2021 Jun 1;158(1):18. doi: 10.1186/s41065-021-00184-y.
6
The genetics of vascular birthmarks.血管性胎记的遗传学。
Clin Dermatol. 2022 Jul-Aug;40(4):313-321. doi: 10.1016/j.clindermatol.2022.02.006. Epub 2022 Feb 16.
7
PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling.PIK3CA 突变使肿瘤生长和细胞周期蛋白 D1 的调节与 MEK/ERK 和突变 KRAS 信号脱耦。
Cancer Res. 2010 Sep 1;70(17):6804-14. doi: 10.1158/0008-5472.CAN-10-0409. Epub 2010 Aug 10.
8
Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.整合素β1、肌球蛋白轻链激酶和肌球蛋白IIA是转移性三阴性乳腺癌中MEK抑制后PI3K-AKT信号通路激活所必需的。
Oncotarget. 2016 Sep 27;7(39):63466-63487. doi: 10.18632/oncotarget.11525.
9
How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies.我们如何使用西罗莫司和新制剂:治疗血管异常的药物治疗。
Pediatr Blood Cancer. 2022 Aug;69 Suppl 3:e29603. doi: 10.1002/pbc.29603. Epub 2022 Mar 6.
10
Comprehensive phenotypic and genomic characterization of venous malformations.静脉畸形的综合表型和基因组特征分析。
Hum Pathol. 2024 Mar;145:48-55. doi: 10.1016/j.humpath.2024.02.004. Epub 2024 Feb 15.

引用本文的文献

1
A phase 2 randomized, double-blind trial of ART-001, a selective PI3Kα inhibitor, for the treatment of slow-flow vascular malformations.一项关于选择性PI3Kα抑制剂ART-001治疗低血流性血管畸形的2期随机双盲试验。
Orphanet J Rare Dis. 2025 Feb 10;20(1):64. doi: 10.1186/s13023-025-03564-z.
2
Progressive vascular tumor in infant: A case report and literature review of PIK3CA vascular malformation.婴儿进行性血管肿瘤:PIK3CA 血管畸形病例报告及文献复习。
Childs Nerv Syst. 2024 Apr;40(4):1005-1010. doi: 10.1007/s00381-024-06290-2. Epub 2024 Jan 24.